Shareholding disclosure

ADDEX THERAPEUTICS LTD

Declared position

30.418%

Threshold

Crossed downwards

Timeline

Published

09.09.2026

Transaction

02.09.2026

Voting rights breakdown

Voting rights acquired3.838%

Voting rights sold30.418%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

ZA01-000000000SLD7

Beneficial owner

ADDEX THERAPEUTICS LTD

Declared address

Addex Therapeutics, 1228 Plan-Les-Ouates, CH

The exercise price of 6,971,992 ESOP was repriced to CHF 0.026 on September 2, 2026

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

ADDEX THERAPEUTICS LTD

Addex Therapeutics Ltd09.09.2026ZA01-000000000SLD7

Disclosure summary

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd on the disposal side, published by SIX Exchange Regulation on 09.09.2026, at 30.418% of voting rights. Notice category: Single shareholder.

Disclosed position

30.418%

Voting rights sold

Voting rights acquired3.838%

Voting rights sold30.418%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd, published on 09.09.2026.

Publication date09.09.2026

Transaction date02.09.2026

Issuing companyAddex Therapeutics Ltd

Beneficial ownerADDEX THERAPEUTICS LTD

Declared addressAddex Therapeutics, 1228 Plan-Les-Ouates, CH

CategorySingle shareholder

Voting rights acquired3.838%

Voting rights sold30.418%

Below threshold0%

ExchangeXSWX

Notification IDZA01-000000000SLD7

Commercial register

CHE-113.514.094

Registered

Zefix record

Conditions

The exercise price of 6,971,992 ESOP was repriced to CHF 0.026 on September 2, 2026

Source: SIX Exchange Regulation · Publication date: 09.09.2026

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open